BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29163543)

  • 1. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
    Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
    Front Immunol; 2017; 8():1482. PubMed ID: 29163543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
    Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
    Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
    Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
    Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses.
    Kampan NC; Kartikasari AER; Deceneux C; Madondo MT; McNally OM; Flanagan KL; Aziz NA; Stephens AN; Reynolds J; Quinn MA; Plebanski M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
    Müller M; Herrath J; Malmström V
    Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between effector-type regulatory T cells and immune checkpoint expression on CD8
    Sato S; Matsushita H; Shintani D; Kobayashi Y; Fujieda N; Yabuno A; Nishikawa T; Fujiwara K; Kakimi K; Hasegawa K
    BMC Cancer; 2022 Apr; 22(1):437. PubMed ID: 35449092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
    Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
    Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
    Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
    Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells and IL-17A levels in noninfectious uveitis.
    Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.
    Yan F; Du R; Wei F; Zhao H; Yu J; Wang C; Zhan Z; Ding T; Ren X; Chen X; Li H
    Cancer Immunol Immunother; 2015 Nov; 64(11):1475-85. PubMed ID: 26280204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
    Zhou Q; Hu Y; Howard OM; Oppenheim JJ; Chen X
    Cytokine; 2014 Jan; 65(1):56-64. PubMed ID: 24080164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
    Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
    J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.
    Hu Y; Xiao H; Shi T; Oppenheim JJ; Chen X
    Immunology; 2014 Jun; 142(2):193-201. PubMed ID: 24383743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.
    Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ
    Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
    Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.